These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 36352222)

  • 1. Spatial genomics maps the structure, nature and evolution of cancer clones.
    Lomakin A; Svedlund J; Strell C; Gataric M; Shmatko A; Rukhovich G; Park JS; Ju YS; Dentro S; Kleshchevnikov V; Vaskivskyi V; Li T; Bayraktar OA; Pinder S; Richardson AL; Santagata S; Campbell PJ; Russnes H; Gerstung M; Nilsson M; Yates LR
    Nature; 2022 Nov; 611(7936):594-602. PubMed ID: 36352222
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dynamics of genomic clones in breast cancer patient xenografts at single-cell resolution.
    Eirew P; Steif A; Khattra J; Ha G; Yap D; Farahani H; Gelmon K; Chia S; Mar C; Wan A; Laks E; Biele J; Shumansky K; Rosner J; McPherson A; Nielsen C; Roth AJ; Lefebvre C; Bashashati A; de Souza C; Siu C; Aniba R; Brimhall J; Oloumi A; Osako T; Bruna A; Sandoval JL; Algara T; Greenwood W; Leung K; Cheng H; Xue H; Wang Y; Lin D; Mungall AJ; Moore R; Zhao Y; Lorette J; Nguyen L; Huntsman D; Eaves CJ; Hansen C; Marra MA; Caldas C; Shah SP; Aparicio S
    Nature; 2015 Feb; 518(7539):422-6. PubMed ID: 25470049
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Archival single-cell genomics reveals persistent subclones during DCIS progression.
    Wang K; Kumar T; Wang J; Minussi DC; Sei E; Li J; Tran TM; Thennavan A; Hu M; Casasent AK; Xiao Z; Bai S; Yang L; King LM; Shah V; Kristel P; van der Borden CL; Marks JR; Zhao Y; Zurita AJ; Aparicio A; Chapin B; Ye J; Zhang J; Gibbons DL; ; Sawyer E; Thompson AM; Futreal A; Hwang ES; Wesseling J; Lips EH; Navin NE
    Cell; 2023 Aug; 186(18):3968-3982.e15. PubMed ID: 37586362
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Whole-Exome Sequencing Analysis of the Progression from Non-Low-Grade Ductal Carcinoma
    Pareja F; Brown DN; Lee JY; Da Cruz Paula A; Selenica P; Bi R; Geyer FC; Gazzo A; da Silva EM; Vahdatinia M; Stylianou AA; Ferrando L; Wen HY; Hicks JB; Weigelt B; Reis-Filho JS
    Clin Cancer Res; 2020 Jul; 26(14):3682-3693. PubMed ID: 32220886
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genome evolution in ductal carcinoma in situ: invasion of the clones.
    Casasent AK; Edgerton M; Navin NE
    J Pathol; 2017 Jan; 241(2):208-218. PubMed ID: 27861897
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparable cancer-relevant mutation profiles in synchronous ductal carcinoma in situ and invasive breast cancer.
    Bergholtz H; Kumar S; Wärnberg F; Lüders T; Kristensen V; Sørlie T
    Cancer Rep (Hoboken); 2020 Jun; 3(3):e1248. PubMed ID: 32671987
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Three-dimensional modelling identifies novel genetic dependencies associated with breast cancer progression in the isogenic MCF10 model.
    Maguire SL; Peck B; Wai PT; Campbell J; Barker H; Gulati A; Daley F; Vyse S; Huang P; Lord CJ; Farnie G; Brennan K; Natrajan R
    J Pathol; 2016 Nov; 240(3):315-328. PubMed ID: 27512948
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evidence that molecular changes in cells occur before morphological alterations during the progression of breast ductal carcinoma.
    Castro NP; Osório CA; Torres C; Bastos EP; Mourão-Neto M; Soares FA; Brentani HP; Carraro DM
    Breast Cancer Res; 2008; 10(5):R87. PubMed ID: 18928525
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Single-cell genetic analysis of ductal carcinoma in situ and invasive breast cancer reveals enormous tumor heterogeneity yet conserved genomic imbalances and gain of MYC during progression.
    Heselmeyer-Haddad K; Berroa Garcia LY; Bradley A; Ortiz-Melendez C; Lee WJ; Christensen R; Prindiville SA; Calzone KA; Soballe PW; Hu Y; Chowdhury SA; Schwartz R; Schäffer AA; Ried T
    Am J Pathol; 2012 Nov; 181(5):1807-22. PubMed ID: 23062488
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The harsh microenvironment in early breast cancer selects for a Warburg phenotype.
    Damaghi M; West J; Robertson-Tessi M; Xu L; Ferrall-Fairbanks MC; Stewart PA; Persi E; Fridley BL; Altrock PM; Gatenby RA; Sims PA; Anderson ARA; Gillies RJ
    Proc Natl Acad Sci U S A; 2021 Jan; 118(3):. PubMed ID: 33452133
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mixed ductal-lobular carcinomas: evidence for progression from ductal to lobular morphology.
    McCart Reed AE; Kutasovic JR; Nones K; Saunus JM; Da Silva L; Newell F; Kazakoff S; Melville L; Jayanthan J; Vargas AC; Reid LE; Beesley J; Chen XQ; Patch AM; Clouston D; Porter A; Evans E; Pearson JV; Chenevix-Trench G; Cummings MC; Waddell N; Lakhani SR; Simpson PT
    J Pathol; 2018 Apr; 244(4):460-468. PubMed ID: 29344954
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Appraisal of the technologies and review of the genomic landscape of ductal carcinoma in situ of the breast.
    Pang JM; Gorringe KL; Wong SQ; Dobrovic A; Campbell IG; Fox SB
    Breast Cancer Res; 2015 Jun; 17(1):80. PubMed ID: 26078038
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Analysis of p53 mutations in cells taken from paraffin-embedded tissue sections of ductal carcinoma in situ and atypical ductal hyperplasia of the breast.
    Keohavong P; Gao WM; Mady HH; Kanbour-Shakir A; Melhem MF
    Cancer Lett; 2004 Aug; 212(1):121-30. PubMed ID: 15246568
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transcriptome and genome evolution during HER2-amplified breast neoplasia.
    Lu P; Foley J; Zhu C; McNamara K; Sirinukunwattana K; Vennam S; Varma S; Fehri H; Srivastava A; Zhu S; Rittscher J; Mallick P; Curtis C; West R
    Breast Cancer Res; 2021 Jul; 23(1):73. PubMed ID: 34266469
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phosphatidylinositol-3-kinase and AKT1 mutations occur early in breast carcinoma.
    Dunlap J; Le C; Shukla A; Patterson J; Presnell A; Heinrich MC; Corless CL; Troxell ML
    Breast Cancer Res Treat; 2010 Apr; 120(2):409-18. PubMed ID: 19418217
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Heterogeneous versus homogeneous genetic nature of multiple foci of in situ carcinoma of the breast.
    Volante M; Sapino A; Croce S; Bussolati G
    Hum Pathol; 2003 Nov; 34(11):1163-9. PubMed ID: 14652818
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Re-evaluating early breast neoplasia.
    Moulis S; Sgroi DC
    Breast Cancer Res; 2008; 10(1):302. PubMed ID: 18279539
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clonal evolution in cancer.
    Greaves M; Maley CC
    Nature; 2012 Jan; 481(7381):306-13. PubMed ID: 22258609
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Age-specific gene expression signatures for breast tumors and cross-species conserved potential cancer progression markers in young women.
    Colak D; Nofal A; Albakheet A; Nirmal M; Jeprel H; Eldali A; Al-Tweigeri T; Tulbah A; Ajarim D; Malik OA; Inan MS; Kaya N; Park BH; Bin Amer SM
    PLoS One; 2013; 8(5):e63204. PubMed ID: 23704896
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Breast cancer heterogeneity: parallel evolution or conscious uncoupling?
    Natrajan RC
    J Pathol; 2015 Sep; 237(1):1-3. PubMed ID: 25953517
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.